Related references
Note: Only part of the references are listed.Loop Grafting between Similar Local Environments for Fc-Silent Antibodies
Samo Lesnik et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
The Increasingly Human and Profitable Monoclonal Antibody Market
Antonio L. Grilo et al.
TRENDS IN BIOTECHNOLOGY (2019)
Antigen binding allosterically promotes Fc receptor recognition
Jun Zhao et al.
MABS (2019)
The Fab portion of immunoglobulin G contributes to its binding to Fcγ receptor III
Rina Yogo et al.
SCIENTIFIC REPORTS (2019)
CHARMM-GUI Glycan Modeler for modeling and simulation of carbohydrates and glycoconjugates
Sang-Jun Park et al.
GLYCOBIOLOGY (2019)
IgG Fc engineering to modulate antibody effector functions
Xinhua Wang et al.
PROTEIN & CELL (2018)
Evaluating Anti-CD32b F(ab) Conformation Using Molecular Dynamics and Small-Angle X-Ray Scattering
Emma J. Sutton et al.
BIOPHYSICAL JOURNAL (2018)
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
Frederick Arce Vargas et al.
CANCER CELL (2018)
Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
Myrthe E. Sonneveld et al.
FRONTIERS IN IMMUNOLOGY (2018)
Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab
Udupi A. Ramagopal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Immunoglobulin isotype knowledge and application to Fc engineering
Randall J. Brerski et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding
Jinghua Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies
Zhi Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Structure-Based Function Prediction of Uncharacterized Protein Using Binding Sites Comparison
Janez Konc et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
CHARMM Additive All-Atom Force Field for Carbohydrate Derivatives and Its Utility in Polysaccharide and Carbohydrate-Protein Modeling
Olgun Guvench et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose
Claudia Ferrara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CHARMM: The Biomolecular Simulation Program
B. R. Brooks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Software news and updates - CHARNIM-GUI: A web-based grraphical user interface for CHARMM
Sunhwan Jo et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2008)
Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells
John O. Richards et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Statistical potential for assessment and prediction of protein structures
Min-Yi Shen et al.
PROTEIN SCIENCE (2006)
Engineered antibody Fc variants with enhanced effector function
GA Lazar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Calculation of absolute protein-ligand binding affinity using path and endpoint approaches
MS Lee et al.
BIOPHYSICAL JOURNAL (2006)
MUSCLE: multiple sequence alignment with high accuracy and high throughput
RC Edgar
NUCLEIC ACIDS RESEARCH (2004)
New analytic approximation to the standard molecular volume definition and its application to generalized born calculations
MS Lee et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
Novel generalized Born methods
MS Lee et al.
JOURNAL OF CHEMICAL PHYSICS (2002)
The human low affinity Fcγ receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties
K Maenaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design
EO Saphire et al.
SCIENCE (2001)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
Share Paper
